Catalyst Wire Dossier Catalyst Wire Dossier

KRP-104

· ActivX Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KRP-104, covering 2013-08-22 to 2014-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone [Phase 2]

See pricing